In the Spotlight - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for November 2011.

Pharmaceutical Technology
pp. 24

Editors' Picks of Pharmaceutical Science & Technology Innovations

FDA's recent guidance on process validation emphasizes scientific understanding and the effective control of manufacturing processes. The document reflects the shift towards monitoring and measuring process parameters to ensure product quality. This month's products can help drugmakers continue to verify that their production lines are operating as expected. A new mixer from Silverson provides users with information about the mixing process. Software from TrackWise helps companies track documents related to corrective actions. A process-control suite from Honeywell is designed to enable central control of all systems at a manufacturing plant.

Software centrally monitors process-control systems

TrackWise Auditing Solutions Sparta Systems
Sparta Systems's TrackWise Preclinical GLP and Clinical GCP Auditing Solutions includes a wide range of document-control functions that enable the transfer of attachments, through a web service, to other enterprise applications. The software is designed to manage all information securely in a centralized, scalable, and reliable enterprise system. It also generates reports to monitor and review auditor resource allocation and scheduling, draft and formal audit reports, and reports to track and trend findings and corrective actions to enable continuous improvement.

The system allows an administrator to define user roles, as well as specific permissions and assignments directly from pre-existing enterprise applications. The creation of user accounts for supplier and customer access portals and web forms can be automated. TrackWise can also interact with other enterprise software systems through a web services interface, thus enabling constant communication with enterprise resource planning, customer relationship management, laboratory information management systems, and manufacturing execution systems software.

Mixer performs under full-scale conditions

Verso In-Line Laboratory Mixer Silverson Machines
Silverson's Verso In-Line laboratory mixer is equipped with a digital tachometer, integral programmable timer, and simultaneous amp reading, thus allowing the user to monitor power draw and mixer speed over time throughout the mixing process. It operates at variable speeds as high as 8000 rpm. The unit incorporates single or multistage interchangeable workheads and stator screens.

The mixer has a 1-hp drive unit and a self-pumping flow rate of as much as 6.5 gal/min. Its instrumentation is augmented by the Silverson DataLogger program, which allows the user to plot information in a graph and archive readings or integrate them into databases. The Verso is a sanitary mixer designed for clean-in-place capabilities. The unit incorporates the design features of larger mixers in Silverson's UHS range.

Software manages information in a centralized enterprise system

Process-control suite Honeywell Process Solutions
Honeywell's vendor-neutral process-control suite allows plant operators to centrally monitor and control process-control systems. It is designed to avoid the information silos that can be created by Advanced Process Control (APC) systems.

The suite contains Honeywell's Loop Scout software, which gives control engineers the ability to identify and correct poorly performing control loops. In addition, the Control Performance Monitor detects, identifies, diagnoses, and remedies regulatory and APC asset issues throughout the plant.

The Honeywell Process Solutions suite can work with various APC technologies and processing facilities, thus contributing to consistent performance benchmarking across the enterprise and ensuring that proper corrective action is taken if necessary.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here